2021-May-18 03:46
Society_Culture
2021-May-1  12:44

Iran Hopes to Finish Coronavirus Vaccination by End of Winter

TEHRAN (FNA)- Deputy Health Minister and Head of Iran Food and Drug Administration (IFDA) Mohammad Reza Shanehsaz announced that the country hopes to complete public vaccination against COVID-19 virus by the end of this winter.

“Within 45 days, we managed to reach the daily production of 45 million masks. We are completely self-sufficient in the field of diagnostic (coronavirus) kits, and in area of coronavirus medications, we managed to develop and manufacture the needed medicines in less than three months,” Shanehsaz told reporters in a press conference on Saturday.

"We have also managed to make good success in the development and production of vaccines," he added.

“Today we hope to produce the first million-dose batch of the vaccine in June, and we can complete the public vaccination by the end of the (Iranian) year (March 20, 2022),” Shanehsaz said.

Head of the information office of the Headquarters for Executing Imam Khomeini's Order (HEIKO) Hojjat Niki Maleki tweeted on Friday that the efforts of the Iranian scientists have yielded fruit and within a couple of weeks the country will produce some 1 million doses of COV-Iran Barekat vaccine.

He added that another 3 million doses are expected to be produced by June 20.

In relevant remarks last week, Head of HEIKO Mohammad Mokhber said that nearly 30 million doses of COV-Iran Barekat vaccine will be produced and delivered to the health ministry.

“One million doses of the vaccine will be produced this month, 3 million doses next month, 10 to 12 million doses in July, and 13 to 15 million doses in August,” Mokhber said last Sunday, adding that the vaccines would be given to the Health Ministry for vaccination.

He noted that from September, 20 million doses of the vaccine would be produced monthly.

The official pointed out that people's concerns regarding the virus would be resolved within the next 3 to 4 months.

He concluded that all Iranian vaccines had achieved the human testing phase and desirable results, but COV-Iran Barekat has had fewer side effects.